NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 74% to ILMN. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-04-29 | Canaccord Genuity | Maintains | Hold -> Hold |
2025-04-10 | Barclays | Maintains | Underweight -> Underweight |
2025-04-08 | RBC Capital | Maintains | Outperform -> Outperform |
2025-04-07 | Citigroup | Maintains | Neutral -> Neutral |
2025-03-12 | RBC Capital | Maintains | Outperform -> Outperform |
2025-03-11 | Stephens & Co. | Reiterate | Overweight -> Overweight |
2025-03-11 | Canaccord Genuity | Maintains | Hold -> Hold |
2025-03-05 | Baird | Maintains | Neutral -> Neutral |
2025-03-04 | Citigroup | Maintains | Neutral -> Neutral |
2025-02-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
2025-02-10 | Barclays | Downgrade | Equal-Weight -> Underweight |
2025-02-10 | Piper Sandler | Maintains | Overweight -> Overweight |
2025-02-07 | Guggenheim | Maintains | Buy -> Buy |
2025-02-07 | RBC Capital | Maintains | Outperform -> Outperform |
2025-02-07 | Canaccord Genuity | Maintains | Hold -> Hold |
2025-02-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
2025-01-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
2024-12-11 | Citigroup | Downgrade | Buy -> Neutral |
2024-11-12 | Stephens & Co. | Maintains | Overweight -> Overweight |
2024-11-12 | Morgan Stanley | Reiterate | Equal-Weight |
2024-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
2024-11-06 | Baird | Maintains | Neutral -> Neutral |
2024-11-05 | TD Cowen | Maintains | Buy -> Buy |
2024-11-05 | UBS | Maintains | Neutral -> Neutral |
2024-11-05 | RBC Capital | Maintains | Outperform -> Outperform |
2024-11-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
2024-11-05 | JP Morgan | Maintains | Neutral -> Neutral |
2024-11-05 | Canaccord Genuity | Maintains | Hold -> Hold |
2024-11-05 | Citigroup | Maintains | Buy -> Buy |
2024-10-17 | Leerink Partners | Maintains | Outperform -> Outperform |